Eansor Norman David
- SEC CIK
- 0001270905
No open-market purchases or sales filed in the past year.
Current role at each company
- MRKR Marker Therapeutics, Inc.Directoras of Nov 19, 2025
- TECH BIO-TECHNE CorpPresident-Protein Sciencesas of Nov 16, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Eansor Norman David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MRKR Marker Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2023 (view filing) | Mar 16, 2021 | 814 daysLate | Eansor Norman DavidDirector | PPurchase | +14.3K | $17.50 | +$250.0K | +588.3%16.7K after |
TECH BIO-TECHNE Corp
President-Protein Sciences2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2021 (view filing) | Nov 12 | 4 days | Eansor Norman DavidPresident-Protein Sciences | SSale | −27.2K | $504.00 | −$13.7M | −95.4%1.32K after | 10 lots |
| Sep 2, 2021 (view filing) | Aug 31 | 2 days | Eansor Norman DavidPresident-Protein Sciences | SSale | −1.54K | $503.07 | −$773.7K | −53.9%1.32K after |